Email Facebook Twitter

UPDATE: #COPL set timeline for Q2/Q3 Nigeria drilling programme
RESULTS: IFA led wealth managers AFH Financial results show strong growth

Glaxosmithkline Broker Ratings

Broker Ratings for Glaxosmithkline (GSK)

Share Price: 1,581.00Bid: 1,582.00Ask: 1,582.80Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.80Spread as %: 0.05%Open: 1,567.00High: 1,592.40Low: 1,567.00Yesterday’s Close: 1,581.00

Broker Recommendations for Glaxosmithkline (GSK)
Date Broker Rating Old Target New Target Change
06-Feb-19Deutsche BankHold-1,520.00Reiteration
21-Jan-19Liberum CapitalHold-1,510.00Reiteration
18-Jan-19Shore CapitalHold--Downgrade
19-Dec-18Liberum CapitalHold1,700.001,700.00Reiteration
10-Dec-18Deutsche BankHold1,525.001,520.00Reiteration
22-Nov-18Kepler Capital MarketsHold-144.00Reiteration
05-Nov-18Liberum CapitalHold-1,700.00Reiteration
08-Oct-18Deutsche BankHold-1,525.00Reiteration
10-Sep-18Liberum CapitalHold1,700.001,700.00Reiteration
06-Sep-18Deutsche BankHold-1,525.00Reiteration
30-Aug-18Liberum CapitalHold1,630.001,700.00Downgrade
23-Aug-18Berenberg BankBuy1,790.001,790.00Reiteration

Registered members see more Glaxosmithkline broker ratings!
Sign up here for your free account.

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.